Regulatory Endpoints
Regulatory Endpoints is a formal measure or observation used in pharmacological studies to assess the safety, efficacy, quality, or risk-benefit profile of a drug or biologic for regulatory decision-making.
17
Publications
586
Citations
69
Authors
37
Institutions
Publications per year
2017–2026
9
Parents
17
Integrated QSAR Models to Predict Acute Oral Systemic Toxicity
Davide Ballabio, Francesca Grisoni, Viviana Consonni et al. · Molecular Informatics · 2018 · 47 citations
Pharmacy, Pharmacology, Toxicology +16
1–5 of 17
69
2
h-index
2
h-index
2
h-index
2
h-index
1
h-index
1–5 of 69
37
United States Food and Drug Administration
Silver Spring, United States
2 h-index
8 publications
112 citations
University of Koblenz and Landau
Mainz, Germany
2 h-index
8 publications
168 citations

Canadian Nuclear Laboratories
Deep River, Canada
2 h-index
1 publications
26 citations

Cornell University
Ithaca, United States
2 h-index
4 publications
55 citations

University of Milano-Bicocca
Milan, Italy
1 h-index
4 publications
188 citations
Temple University
Philadelphia, United States
1 h-index
1 publications
46 citations

Covance (United States)
Princeton, United States
1 h-index
1 publications
26 citations
Incyte (United States)
Wilmington, United States
1 h-index
1 publications
26 citations
1–8 of 37
1 publications · 26 citations
2
h-index
CGH · 1 publications · 46 citations
1
h-index
1 publications · 32 citations
1
h-index
1 publications · 14 citations
1
h-index
1 publications · 10 citations
1
h-index
1–5